Non‐invasive tests for fibrosis and liver stiffness predict 5‐year survival of patients chronically infected with hepatitis B virus

Victor de Lédinghen, J. Vergniol, Christine Barthe, Juliette Foucher, Faïza Chermak, Brigitte Le Bail, Wassil Merrouche, P. Bernard

Alimentary Pharmacology & Therapeutics · 2013 · 108 citations · 38 references

Abstract

Liver stiffness measurement or FibroTest can predict survival in chronic HBV infection. Thus, these tools may help physicians to early assess prognosis and discuss specific treatments, such as liver transplantation.

References

38